[Advances in the topical steroid treatment of inflammatory bowel diseases].
作者信息
Díaz Blasco J, Robledo Andrés P
机构信息
Servicio de Aparato Digestivo, Hospital S. Pedro de Alcántara, Cáceres.
出版信息
Rev Esp Enferm Dig. 1995 Nov;87(11):802-7.
PMID:8534536
Abstract
摘要
相似文献
1
[Advances in the topical steroid treatment of inflammatory bowel diseases].
Rev Esp Enferm Dig. 1995 Nov;87(11):802-7.
2
The new steroids: clinical experience in ulcerative colitis.
Mt Sinai J Med. 1990 Oct;57(5):293-6.
3
[Budesonide and inflammatory bowel disease].
Gastroenterol Hepatol. 1999 Dec;22(10):525-32.
4
[Locally acting glucocorticoids in chronic intestinal inflammation].
Ned Tijdschr Geneeskd. 1994 Dec 17;138(51):2533-5.
5
[Non-halogenated glucocorticoids in the treatment of psoriasis].
Tidsskr Nor Laegeforen. 1982 Mar 30;102(9-10):560-1.
6
[Budesonide in acute attacks of Crohn disease of medium intensity].
Gastroenterol Clin Biol. 1995 Apr;19(4):459-60.
7
[New therapeutic data in inflammatory colitis].
Ann Gastroenterol Hepatol (Paris). 1996 Jan-Feb;32(1):10.
8
[Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease].
Internist (Berl). 1998 Sep;39(9 Suppl Auf Dem We):1-8.
9
The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
Mediators Inflamm. 1998;7(3):137-40. doi: 10.1080/09629359891036.
10
[Pharmacotherapeutic compass 1998].
Ned Tijdschr Geneeskd. 1998 Jun 6;142(23):1347-8.
引用本文的文献
1
Oral budesonide for induction of remission in ulcerative colitis.
Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD007698. doi: 10.1002/14651858.CD007698.pub3.
Zotero 插件